# Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study

> **NCT03066089** · PHASE4 · COMPLETED · sponsor: **Chemical Resources** · enrollment: 104 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Fenfuro

## Key facts

- **NCT ID:** NCT03066089
- **Lead sponsor:** Chemical Resources
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-14
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03066089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03066089, "Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03066089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*